Literature DB >> 22738256

Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.

Qiugen Zhou1, Shengjie Wu, Jianping Jiang, Jianwei Tian, Jianghua Chen, Xueqing Yu, Pingyan Chen, Changlin Mei, Fei Xiong, Wei Shi, Wei Zhou, Xusheng Liu, Shiren Sun, D I Xie, Jun Liu, Xin Xu, Min Liang, Fanfan Hou.   

Abstract

AIM: Whether the burden of advanced oxidation protein products (AOPP) accumulation, a marker of oxidative stress, is affected by dialysis modality remains unclear. We compared the serum levels of AOPP in patients on haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) and tested the hypothesis that an accumulation of AOPP was an independent risk factor for cardiovascular disease.
METHODS: This was a cross-section study. A total of 2095 patients (1539 HD, 556 CAPD) were recruited from the nine largest dialysis centres in China. Persons in medical centres for disease screening were selected as controls. Patients maintained on HD were dialyzed twice or thrice weekly. CAPD patients used lactate-buffered, glucose-containing solutions. The patients' data were abstracted from the medical record. The serum levels of AOPP were determined by spectrophotometric detection.
RESULTS: The levels of AOPP were significantly elevated in both HD and CAPD patients compared to healthy controls. Accumulation of AOPP was more significant in HD compared to CAPD population. Meanwhile, AOPP accumulation was associated with the presence of ischaemic heart disease (IHD) only in HD, but not CAPD patients. A higher proportion of IHD was found in the HD population among those with higher levels of AOPP in each category of age and irrespective of the presence or absence of high triglyceride. Multivariate regression analysis indicated that accumulation of AOPP was an independent risk factor for IHD in HD population.
CONCLUSION: Accumulation of AOPP was more significant in HD compared to CAPD patients. The level of AOPP was independently associated with IHD only in HD patients.
© 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738256     DOI: 10.1111/j.1440-1797.2012.01640.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  13 in total

1.  The therapeutic effects of anti-oxidant and anti-inflammatory drug quercetin on aspiration-induced lung injury in rats.

Authors:  Mehmet Ziya Yilmaz; Aygul Guzel; Aysun Caglar Torun; Ali Okuyucu; Osman Salis; Rifat Karli; Ayhan Gacar; Tolga Guvenc; Sule Paksu; Volkan Urey; Naci Murat; Hasan Alacam
Journal:  J Mol Histol       Date:  2013-10-13       Impact factor: 2.611

Review 2.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

3.  Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Authors:  Hong Xu; Makoto Watanabe; Abdul Rashid Qureshi; Olof Heimbürger; Peter Bárány; Björn Anderstam; Monica Eriksson; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

4.  Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.

Authors:  Anthony J Valente; Tadashi Yoshida; Robert A Clark; Patrice Delafontaine; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Free Radic Biol Med       Date:  2013-02-20       Impact factor: 7.376

Review 5.  AOPPs and the progression of kidney disease.

Authors:  Wei Cao; Fan Fan Hou; Jing Nie
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

6.  Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients.

Authors:  Gülcan Güntaş; Burhan Engin; Özlem Balcı Ekmekçi; Zekayi Kutlubay; Hakan Ekmekci; Abdullah Songür; Tuğba Kevser Üstünbaş Uzunçakmak; Hayriye Ertem Vehid; Server Serdaroğlu; Yalçın Tüzün; Hafize Uzun
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

7.  Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patients.

Authors:  Chun Zhou; Yuanyuan Zhang; Jianghua Chen; Changlin Mei; Fei Xiong; Wei Shi; Wei Zhou; Xusheng Liu; Shiren Sun; Jianwei Tian; Ziliang Ye; Qimeng Wu; Xianhui Qin; Jianping Jiang; Fan Fan Hou
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

8.  Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report.

Authors:  Jolanta Zuwala-Jagiello; Eugenia Murawska-Cialowicz; Monika Pazgan-Simon
Journal:  Biomed Res Int       Date:  2015-11-19       Impact factor: 3.411

9.  An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study.

Authors:  Elena Gonzalez; Maria-Auxiliadora Bajo; Juan J Carrero; Bengt Lindholm; Cristina Grande; Rafael Sánchez-Villanueva; Gloria Del Peso; Mariana Díaz-Almirón; Pedro Iglesias; Juan J Díez; Rafael Selgas
Journal:  Oxid Med Cell Longev       Date:  2015-10-25       Impact factor: 6.543

Review 10.  Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature.

Authors:  Vassilios Liakopoulos; Stefanos Roumeliotis; Xenia Gorny; Theodoros Eleftheriadis; Peter R Mertens
Journal:  Oxid Med Cell Longev       Date:  2017-12-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.